JHS Biomateriais

Founded in March 1993, JHS Biomaterials develops Synthetic Hydroxyapatite-based bone grafts with a focus on serving the medical and dental areas. We work with state-of-the-art technology, valuing the production of materials with standardized quality, in addition to maintaining active research and the search for innovation. Due to the solid academic-scientific background of our founders, we always value professionals and continuous training. In addition to qualified technicians, we have a modern structure to ensure the best results. Our products are endorsed by masters dissertations, doctoral theses and papers published in congresses and scientific journals. We have a unique quality system that...

Biomateriais,enxerto ósseo,hidroxiapatita,bucomaxilo,facial,órtese,prótese,vidro bioativo,osteocondutor,osteoindutor,col hap 91,and hap 91

Jhs biomateriais operates in the Biotechnology research industry.

Jhs biomateriais's revenue is 11m - 100m

Jhs biomateriais has 11 - 50 employees.